Zhenzhong Ai

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The aim of the study was to evaluate the efficacy and safety of intratumoral chemotherapy with paclitaxel liposome combined with systemic chemotherapy as induction therapy in clinical stage III unresectable non-small cell lung cancer (NSCLC). Between January 2011 and July 2014, 48 patients, stage III, performance status 0-1, with unresectable clinical stage(More)
  • 1